NVG-16859-25506
4 vaccinations
4 coded responses
45 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Registered in v-safe
- 2021-04-07
- 2021-04-08
- 2021-04-11
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Axillary lymph node swelling (injection site arm)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-04-27
- 2021-04-28
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-30
- 2021-06-06
- 2021-07-23
- 2021-10-22
-
2021-11-19
Dose 3 — Moderna
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: Swollen axillary lymph nodes (injection side)MedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymph nodes remain swollen (injection side)MedDRA releases: 2024-11 · check-in free text available
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-26
- 2021-12-31
- 2022-02-18
- 2022-05-22
-
2022-09-02
Dose 4 — Moderna
-
2022-09-03
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-05
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-09-06
- 2022-09-07
- 2022-09-08
- 2022-09-09
- 2022-09-16
- 2022-09-25
- 2022-09-30
- 2022-10-07
- 2022-10-14
-
2022-12-02
Survey response — 3 months, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for COVID - see belowMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-06
-
2022-12-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Moderna | No |
| 4 | 2022-09-02 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymph node swelling (injection site arm)
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen axillary lymph nodes (injection side)
Systemic reaction (other): Axillary lymph nodes remain swollen (injection side)
Release 12 — 3 months, dose 4
Symptoms: Tested positive for COVID - see below
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release